This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A 15-Year Experience

Chung-Yau Lo, FRCS(Edin); King-Yin Lam, FRCPA; Annie W. C. Kung, MD, FRCP(Edin); Karen S. L. Lam, MD, FRCP, FRACP; Peter H. M. Tung, FRCS(Edin); Sheung-Tat Fan, MS, FRCS(Glasg)

Arch Surg. 1997;132(8):926-930.

Abstract
Objective
To describe our experience in the management of patients with pancreatic insulinomas, emphasizing the need for preoperative localization and the outcome of surgical treatment.

Design
A case series.

Setting
A university hospital in Hong Kong.

Patients
From 1981 to 1995, 27 patients with pancreatic insulinomas were surgically treated; the mean follow-up was 25.4 months.

Main Outcome Measures
Postoperative morbidity and euglycemia during the follow-up period.

Results
The accuracy of tumor localization by ultrasonography, computed tomography, and angiography was 33%, 44%, and 52%, respectively. Venous sampling for an insulin assay regionalized 90% of the tumors. In 24 patients with solitary tumors, most lesions detected or missed by preoperative localization could be either seen (n=14) or palpated (n=22). Intraoperative ultrasonography (n=17) has been routinely performed since 1987; nonpalpable tumors were imaged in 2 of 15 patients with solitary tumors. Eight solitary occult tumors were detected by palpation alone or a combination of palpation and intraoperative ultrasonography. Operative mortality occurred in 1 (3.7%) of the 27 patients, while major morbidity developed in 9 (33%) of the patients. Euglycemia was achieved in 25 patients. Surgery cured all patients with benign insulinomas, whereas the cure rate for patients with malignant neoplasms was only 33%. The type of surgical treatment or correct preoperative localization did not affect the outcome of surgery.

Conclusions
Pancreatic insulinomas can be readily localized intraoperatively despite failed preoperative localization studies. Surgical treatment cured benign adenomas but was associated with notable morbidity.

Arch Surg. 1997;132:926-930

Author Affiliations
From the Departments of Surgery (Drs Lo, Tung, and Fan), Pathology (Dr K.-Y. Lam), and Medicine (Drs Kung and K. S. L. Lam), The University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Approach and Perioperative Complications Determine Short-Term Outcomes in Patients with Insulinoma: Results of a Bi-Institutional Study
Roland et al.
Ann. Surg. Oncol. 2008;15:3532-3537.
ABSTRACT | FULL TEXT  

The Role of Intra-Arterial Calcium Stimulation Test with Hepatic Venous Sampling (IACS) in the Management of Occult Insulinomas
Tseng et al.
Ann. Surg. Oncol. 2007;14:2121-2127.
ABSTRACT | FULL TEXT  

Laparoscopic distal pancreatectomy with splenic preservation for serous cystadenoma: a case report and literature review.
Aluka et al.
SURG INNOV 2006;13:94-101.
ABSTRACT  

Laparoscopic Localization and Resection of Insulinomas
Jaroszewski et al.
Arch Surg 2004;139:270-274.
ABSTRACT | FULL TEXT  

Intraoperative Ultrasound and Preoperative Localization Detects All Occult Insulinomas
Hiramoto et al.
Arch Surg 2001;136:1020-1026.
ABSTRACT | FULL TEXT  

Lessons to be learned: a case study approach Insulinoma presenting as a change in personality
Vig et al.
The Journal of the Royal Society for the Promotion of Health 2001;121:56-61.
ABSTRACT  

Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy
Lam et al.
Mol. Pathol. 2000;53:133-136.
ABSTRACT | FULL TEXT